TY - JOUR
T1 - Adult respiratory distress syndrome treated with high-frequency positive pressure ventilation
AU - Flatau, E.
AU - Barzilay, E.
AU - Kaufmann, N.
AU - Lev, A.
AU - Ben-Ami, M.
AU - Kohn, D.
PY - 1981
Y1 - 1981
N2 - Adult respiratory distress syndrome (ARDS) is a severe disease that carries a poor prognosis (50 to 60% mortality). Although modern ventilatory techniques, especially positive end-expiratory pressure ventilation, have reduced the mortality rate somewhat, they are still far from serving as the ideal solution to this grave condition. High-frequency positive pressure ventilation (HFPPV) is a relatively new technique that enables effective alveolar ventilation without creating high intrapulmonary pressures. HFPPV using a conventional ventilator, Bennett MA-1B (Suffex, England), was tried in a 22-yr-old man with ARDS due to pyocyanea sepsis, who had failed to respond to conventional ventilation. A dramatic improvement was achieved within 60 min of increasing the ventilatory rate from 12 to 80/min, with a concomitant decrease of tidal volume from 12 to between 2 and 3 ml/kg. HFPPV may be a useful alternative method in the treatment of patients with ARDS.
AB - Adult respiratory distress syndrome (ARDS) is a severe disease that carries a poor prognosis (50 to 60% mortality). Although modern ventilatory techniques, especially positive end-expiratory pressure ventilation, have reduced the mortality rate somewhat, they are still far from serving as the ideal solution to this grave condition. High-frequency positive pressure ventilation (HFPPV) is a relatively new technique that enables effective alveolar ventilation without creating high intrapulmonary pressures. HFPPV using a conventional ventilator, Bennett MA-1B (Suffex, England), was tried in a 22-yr-old man with ARDS due to pyocyanea sepsis, who had failed to respond to conventional ventilation. A dramatic improvement was achieved within 60 min of increasing the ventilatory rate from 12 to 80/min, with a concomitant decrease of tidal volume from 12 to between 2 and 3 ml/kg. HFPPV may be a useful alternative method in the treatment of patients with ARDS.
UR - http://www.scopus.com/inward/record.url?scp=0019406789&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 6790456
AN - SCOPUS:0019406789
SN - 1565-1088
VL - 17
SP - 453
EP - 456
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 6
ER -